Suppr超能文献

使用 Liberase DH 酶分离人原始和初级卵巢卵泡:在临床环境中的应用方案。

Enzymatic isolation of human primordial and primary ovarian follicles with Liberase DH: protocol for application in a clinical setting.

机构信息

Department of Gynecology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.

出版信息

Fertil Steril. 2011 Aug;96(2):379-383.e3. doi: 10.1016/j.fertnstert.2011.05.075. Epub 2011 Jun 29.

Abstract

OBJECTIVE

To set up a protocol to isolate human preantral follicles with an enzyme produced in good manufacturing practice conditions for use in a clinical setting.

DESIGN

For follicle isolation, ovarian biopsies were divided into two halves: one was treated with collagenase IA and the other with Liberase DH (Dispase High) Research Grade.

SETTING

Academic research unit.

PATIENT(S): Twelve women undergoing laparoscopy for benign gynecological disease.

INTERVENTION(S): Follicle isolation.

MAIN OUTCOME MEASURE(S): Follicles were counted, their morphology was analyzed, and follicular viability was evaluated by live/dead assays before and after 7 days of in vitro culture. Their structural preservation was assessed after isolation by electron microscopy.

RESULT(S): A total of 1,030 follicles were obtained after isolation: 566 with Liberase DH and 464 with collagenase IA. The percentage of viable follicles (with <10% of dead granulosa cells [GC]) was not found to be statistically different before or after culture in either group (Liberase DH: 95% and 81%, respectively; collagenase: 96% and 87%, respectively). A significant increase in follicle size was observed in both groups after culture. Liberase DH did not affect the ultrastructure of isolated follicles.

CONCLUSION(S): Liberase DH allows isolation of a high number of preantral follicles, maintaining their viability, even after in vitro culture, and their ultrastructure. In addition, Liberase DH can be produced in good manufacturing practice conditions, allowing use of isolated preantral follicles for future clinical applications.

摘要

目的

建立一种方案,使用在良好生产规范条件下生产的酶分离人原始卵泡,以便在临床环境中使用。

设计

对于卵泡分离,将卵巢活检分为两半:一半用胶原酶 IA 处理,另一半用 Liberase DH(Dispase High)研究级处理。

设置

学术研究单位。

患者

12 名因良性妇科疾病接受腹腔镜检查的妇女。

干预

卵泡分离。

主要观察指标

计数卵泡,分析其形态,并通过活/死检测评估卵泡活力,在体外培养 7 天后进行评估。通过电子显微镜评估分离后的卵泡结构保存情况。

结果

分离后共获得 1030 个卵泡:Liberase DH 分离 566 个,胶原酶 IA 分离 464 个。在培养前后,两组中活卵泡(<10%的死亡颗粒细胞[GC])的比例均无统计学差异(Liberase DH:分别为 95%和 81%;胶原酶:分别为 96%和 87%)。两组培养后卵泡大小均显著增加。Liberase DH 不影响分离卵泡的超微结构。

结论

Liberase DH 可分离大量原始卵泡,在体外培养后仍能保持其活力和超微结构。此外,Liberase DH 可以在良好生产规范条件下生产,允许使用分离的原始卵泡进行未来的临床应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验